Published Oct 7, 2026, 1:30 PM ET · Updated a month ago · 1 source
Pfizer’s Tukysa regimen approved in U.S. for front-line breast cancer
Seeking Alpha
·
Original Report
Pfizer’s Tukysa regimen approved in U.S. for front-line breast cancer
Pfizer’s Tukysa regimen approved in U.S. for front-line breast cancer